[Corneal marginal ulcer. Autoimmune diseases, new therapeutic aspects].
Ndiaye
M R
MR
Clinique ophtalmologique, C.H.U. Aristide Le Dantec BP 6015 Dakar Etoile.
Sarr
M H
MH
Ba
E A
EA
Ndoye
P A
PA
Seye-Ndiaye
C
C
Ndiaye
P A
PA
Wade
P A
PA
D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D002648:Child; D003320:Corneal Ulcer / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D003452:Cryosurgery; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012675:Senegal; D013256:Steroids; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D013256:Steroids; D003520:Cyclophosphamide